Merck & Co., Inc. (MRK) short interest & options flow
NYSEMRK closed Tuesday at $141.82, down 4.4% on the week, while its closest pharmaceutical peers gained a median 1.7% over the same period. JNJ added 3.6%, RPRX rose 4.9%, and even LLY and BMY were roughly flat. The Q3 print landed Tuesday afternoon and produced a 2.4% one-day decline, reversing the small bounce Merck had managed off…
MRK cost to
Full pulse commentary is for ORTEX subscribers. The live data picture for MRK below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for MRK are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
- Market cap
- $356.93B
- Next earnings
- 2 Feb 2027
Key data as of 4 Nov 2026
Latest signals on MRK
- Cost to Borrow
MRK cost to
3 Cost to Borrow updates in 30 days
MRK Stock Report — available now on ORTEX
A new long-form analysis for MRK this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumMRK news and analysis
RSSNo long-form analysis yet for MRK. Pulse alerts and the live data picture are available on ORTEX.
Open MRK on ORTEX →Want the live picture for MRK?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MRK — free to start on ORTEX.
Sign up for free →Open MRK on ORTEX